Vivitra 150mg Injection

Vivitra 150mg Injection contains Trastuzumab as the active ingredient and is indicated for HER2-positive breast cancer. In patients with HER2-positive breast cancer, the cancer cells express elevated levels of HER2 proteins, which promote rapid tumour development by acting as a growth signal. This medication is also used to treat metastatic gastric cancer with elevated HER2 protein expression. HER2-positive breast cancers are generally more aggressive in nature. The targeted therapy approach works by selectively binding to the HER2 proteins responsible for cancer cell growth, development, and spread. Effective contraception must be used during treatment and for at least 7 months after the final dose. Vivitra 150mg Injection is not recommended for patients under 18 years of age, patients with severe respiratory distress, or those requiring oxygen therapy. Patients with existing cardiac conditions, breathlessness, or prior exposure to other cancer treatments must inform their physician before commencing therapy. All concurrent medications, including supplements and herbal preparations, must be disclosed to the physician prior to initiating treatment with this medication.

Vivitra 150mg Injection is indicated for its use in the following conditions: Advanced and metastatic breast cancer Metastatic gastric cancer

The protein called HER2 (human epidermal growth factor receptor 2) is found in abundant amounts on the surface of certain cancer cells, where it stimulates cancer growth. Vivitra 150mg Injection selectively binds to HER2 and stops the growth of cancer cells.

Vivitra 150mg Injection shall either be administered before or after surgery. It will be given as an Intravenous infusion for 90 minutes, if well tolerated it shall be administered within 30 minutes for the next doses.

Side effects are unwanted symptoms caused by medicines. Although all drugs can cause side effects, not everyone experiences them. Common Side Effects of Vivitra 150mg Injection are: Headache Fatigue Neutropenia (Low white blood cells) Nausea and Vomiting Rash Diarrhea Infections Fever Infusion reactions (e.g., chills, fever, pain) Anaemia (Low red blood cells) Serious Side Effects of Vivitra 150mg Injection are: Congestive heart failure (CHF) Pulmonary toxicity (Lung issues) Cardiomyopathy (Heart dysfunction) Severe infusion reactions (e.g., difficulty breathing, low blood pressure) Severe allergic reactions (e.g., anaphylaxis) Severe infections (e.g., febrile neutropenia, pneumonia) Embryo-fetal toxicity (Harm to Fetus) Blood cell disorders (e.g., thrombocytopenia, leukopenia) Lung problems (e.g., interstitial pneumonitis)

It is suggested to inform your doctor if you have a history of allergic reactions to Vivitra 150mg Injection to avoid life-threatening complications. If you have a history of lung disorder or breathing problems inform your doctor beforehand before the treatment commencement. Avoid planning for pregnancy and breastfeeding for a minimum of 7 months after the last dose. Monitor your heart parameters regularly during the treatment with Vivitra 150mg Injection as it may impact the functioning of heart.